ZJ9-28610-22492
2 vaccinations
5 coded responses
26 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 037 / NH
- Registered
- 2021-04-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-03
Registered in v-safe
-
2021-04-03
Dose 1 — Moderna
- 2021-04-03
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Injection site warmth — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Injection site warmthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Fatigue or tirednessAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-08
- 2021-04-09
- 2021-04-10
-
2021-04-17
Survey response — day 14, dose 1MedDRA: Arthralgia, Fatigue, Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Myalgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Day 7: Injection site itching, redness (2 dia)Day 8: Injection site pain, swelling, redness 2; fatigue; myalgia; joint painDay 9: injection site redness 3; myalgiaDay 12: fatigue, myalgia, injection site red ring 4Day 14: fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-25
-
2021-05-01
Dose 2 — Moderna
- 2021-05-01
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Itching · Joint pains, Fatigue or tirednessAdult check-in
-
2021-05-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-05-06
- 2021-05-07
-
2021-05-08
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-15
Survey response — day 14, dose 2MedDRA: Fatigue, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth, Post inflammatory pigmentation change — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Fatigue, injection site tenderness, itching, warmth, swelling, post-inflammatory hyperpigmentationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-22
- 2021-05-29
- 2021-06-05
-
2021-06-12
Survey response — day 42, dose 2MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Increased fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-31
-
2021-10-30
Survey response — 6 months, dose 2MedDRA: Fatigue, Increased viscosity of upper respiratory secretion, Sinus congestion, Somnolence — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue & drowsiness, sinus congestion, thick sinus mucusMedDRA releases: 2024-11 · check-in free text available
- 2022-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-03 | Moderna | |
| 2 | 2021-05-01 | Moderna |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site warmth
Release 7 — day 14, dose 1
Symptoms: Day 7: Injection site itching, redness (2 dia)Day 8: Injection site pain, swelling, redness 2; fatigue; myalgia; joint painDay 9: injection site redness 3; myalgiaDay 12: fatigue, myalgia, injection site red ring 4Day 14: fatigue
Release 8 — day 14, dose 2
Symptoms: Fatigue, injection site tenderness, itching, warmth, swelling, post-inflammatory hyperpigmentation
Release 9 — day 42, dose 2
Symptoms: Increased fatigue
Release 10 — 6 months, dose 2
Symptoms: Fatigue & drowsiness, sinus congestion, thick sinus mucus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Increased viscosity of upper respiratory secretion | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Post inflammatory pigmentation change | ✓ | ✓ | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SD | Somnolence | · | · | ✓ |
| SRO | Injection site warmth | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release